Costimulatory connections: CARMIL2 and CD28
Journal of Experimental Medicine · 2025
DOI: 10.1084/jem.20250896 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, 2025. Verfasst von Lawrence P Kane. Beteiligte Einrichtung: Department of Immunology, University of Pittsburgh, Pittsburgh, PA, USA. Hauptthemen laut MEDLINE: CD28 Antigens, CARD Signaling Adaptor Proteins, Guanylate Cyclase. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
In this issue of JEM, Zhang et al. (https://doi.org/10.1084/jem.20250339) report that a gain-of-function mutation in CARMIL2, previously identified in patients, is sufficient to replace the contribution of CD28 to NF-κB activation and downstream effects in T cells, including in the setting of an anti-tumor response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Immunology, University of Pittsburgh, Pittsburgh, PA, USA.
ORCID-Profile: Lawrence P Kane
Zitieren
APA
Kane, L. P. (2025). Costimulatory connections: CARMIL2 and CD28. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20250896
Vancouver
Kane LP. Costimulatory connections: CARMIL2 and CD28. Journal of Experimental Medicine. 2025. doi:10.1084/jem.20250896
BibTeX
@article{Kane2025,
author = {Kane, Lawrence P},
title = {Costimulatory connections: CARMIL2 and CD28},
journal = {Journal of Experimental Medicine},
year = {2025},
doi = {10.1084/jem.20250896}
}
EUVIMED